Smoothie Diet

BYHEALTH reports nearly 15% decline in Q1 revenue

By │Published On: May 6, 2024│2.8 min read│Views: 445│0 Comments on BYHEALTH reports nearly 15% decline in Q1 revenue│
In January to March this year, BYHEALTH said its operating revenue had shrunk 14.87 per cent yoy to RMB$2.65 billion (US$365.54m) in its announcement in end April.

Demand for immune supporting products had come down from the spike last year, the company explained.

sumatra ad banner

“As compared to the same period last year, where immune supporting related products were seeing strong market demand, the company’s revenue in year 2024 Q1 had shown a certain degree of decline from the high base recorded last year.”​

Its same name protein powder brand BYHEALTH saw a boost in popularity in the thick of COVID-19 as the Chinese authorities had encouraged the consumption of protein for supporting the body’s immunity.

In its FY23 results,​ sales of BYHEALTH protein powder had surged 21.45 per cent yoy to RMB$54bn (US$750m).

However, the tide had turned early this year, as sales from this segment had dropped 17.74 per cent to RMB$15.45bn (US$213m).

The decline was uniform across its other flagship brands.

Its joint care supplement, KeyLid for example, also saw sales lowered by 2.06 per cent to RMB$3.73bn (US$51.5m)

Probiotic brand Lifespace reported one of the biggest declines as sales in mainland China dipped 29.48 per cent to RMB$1.2bn (US$1.66m).

Overseas, Lifespace’s revenue was also 5.08 per cent lower than last year to RMB$2.54bn (US$34.95 m).

While sales from offline channels was down 7.55 per cent to RMB$17.22bn (US$237.87m), those coming from online sales revenue had nosedived by 26.53 per cent to RMB$9.09bn (US$125.56m).


Source link

lean body tonic image

Written by : Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.

Share this article:

Leave A Comment